EuropaBio calls for “bold approach to investment” amid EU Biotech Act
The EU Biotech Act was first spoken about in EC President Ursula von der Leyen's political guidelines for 2025 in July 2024.
Regulation
FDA’s revolving door reveals Pazdur as new CDER head
Japan’s MHLW grants orphan status to Kyowa and Orchard’s MLD therapy
FDA ‘green list’ flagging illegal GLP-1RA compounders is long overdue
Big pharma companies hit with FDA warning letters in drug ad clampdown
FDA chief blames decades of regulatory failure for misleading pharma ads
Five takeaway quotes from RFK Jr’s combative Senate hearing
FDA creates new pathway for rare disease drugs, analysts unconvinced
